Glaukos
GKOS
157.71
-14.47
-8.40%
Glaukos
US · GKOS
#1500 by market cap
Listed 2015
157.71
-14.47
-8.40%
Live - 5344 symbols - heartbeat 512s ago
· 2026-10-08 10:00
Pre-market
177.61
+3.15%
After-hours
172.18
0.00%
Overnight
170.79
-0.81%
- Market cap
- 9.30B
- P/E (TTM)i
- -48.23
- P/Bi
- 13.63
- EPSi
- -3.28
- Div yieldi
- 0.00%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on GKOS?
Anonymous reader poll. Unscientific, not investment advice.
About Glaukos
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard A. Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.
- Founded
- 1998
- CEO
- Mr. Thomas W. Burns
- Employees
- 1,094
- Headquarters
- Aliso Viejo, California, United States of America
- Fiscal year end
- 12-31
- Website
- glaukos.com
Company profile
- Exchange
- US
- Symbol
- GKOS
- Market-cap rank
- #1500
- Listing date
- 2015-06-25
- Market cap
- 9.30B
- Float cap
- 8.97B
- Shares out
- 58.98M
- Float shares
- 56.86M
Sectors & themes
Quote time 2026-10-08 10:00:07 · For reference only, not investment advice and not tailored to your situation.